Trial Profile

Phase 2A study of Radspherin

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 20 Feb 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

10 Feb 2023 According to Oncoinvent media release, the company anticipates to publish 15-month and 18-month progression free survival data in the same group of patients at conferences later this year. Also company will provide an update of this clinical study in ovarian cancer patients suffering from peritoneal carcinomatosis and plans for further clinical development during the conference call.
10 Feb 2023 According to Oncoinvent media release, inclusion for phase IIA has been initiated.
28 Jun 2021 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com